The core biopsy was hypercellular (70%) with prominent eosinophilia at the peak, and hypocellular (35%) with mild eosinophilia at the nadir (Figure 2C, D). episodic angioedema with eosinophilia is not yet known, multiple lineages, including lymphocytes, neutrophils and mast cells, are involved and may be related to disease pathogenesis. Whether these cells act directly or promote eosinophilia and eosinophil activation remains to be elucidated. All subjects gave informed consent and were evaluated under an Institutional Review Board-approved protocol (NCT00001406). == Introduction == Episodic angioedema with eosinophilia (EAE), also known as Gleich syndrome, is a rare disorder characterized by recurrent episodes of urticaria, fever, angioedema, weight gain and dramatic eosinophilia that occur at 34 week intervals and resolve with spontaneous diuresis in the absence of therapy. 1Although the syndrome is often classified in the broad category of idiopathic hypereosinophilic syndromes (HES), 2EAE is a distinct eosinophilic syndrome that is remarkably homogenous in clinical presentation, suggesting a common etiology in affected subjects. Early studies described cyclic elevations of serum interleukin (IL)-5 ARS-1630 preceding the rise in eosinophilia, increased numbers of activated T cells and eosinophilic degranulation in the dermis ARS-1630 during symptomatic episodes, 1, 3supporting the hypothesis that activation of blood and tissue eosinophils by T lymphocytes drives EAE. More recently, cycling of additional serum cytokines, including IL-3, IL-6, IL-1 and soluble IL-2 receptor (sIL-2R), has been described in isolated case reports, 4, 5although the sources of these cytokines have not been determined, and some cytokines, such as IL-6, reach maximum levels only after the peak of eosinophilia. 5The presence of a clonal T-cell population with an aberrant CD3CD4+surface phenotype, commonly present in the lymphocytic variant of HES, has been reported in three patients with EAE. 68 Whereas patients with the lymphocytic variant of HES can present with intermittent angioedema and/or urticaria, 9the regular periodicity of eosinophilia and symptoms in EAE is a distinguishing feature that is reminiscent of other cyclic hematologic disorders, such as cyclic neutropenia10, 11and cyclic thrombocytopenia. 12, 13Of note, cycling of multiple additional cell lineages, including eosinophils, platelets, monocytes and lymphocytes, has been reported in patients with these disorders. 10, 13Furthermore, populations of abnormal lymphocytes, specifically large granular lymphocytes, are often present in patients with the adult onset form of cyclic neutropenia11and have been described in cyclic thrombocytopenia. 12Although mutations in neutrophil elastase (ELANE)14have been identified in many patients with cyclic neutropenia, the role of these mutations in neutrophil cycling remains controversial. Unlike patients with cyclic neutropenia, who require therapy once the diagnosis is made to prevent life-threatening complications of neutropenia, patients with EAE can often be followed without therapy providing a unique opportunity to investigate the etiology and pathogenesis of this disorder. In the present study, we identified four patients with definite EAE and monitored their clinical and laboratory Rabbit Polyclonal to ZNF691 characteristics, including absolute cell counts and cytokine responses, over the course of an entire cycle. Our data confirm that eosinophils are likely the primary cell responsible for the pathogenesis of clinical symptoms in EAE; however , cyclic variation in the numbers of peripheral blood cells other than eosinophils, including neutrophils and lymphocytes, was observed in all four patients, suggesting that EAE is a multilineage cell cycling disorder. == Methods == == Baseline clinical assessment of study subjects == All subjects ARS-1630 signed informed consent, and research was performed under an Institutional Review Board-approved protocol (NCT00001406) to.